Negotiable
The date of payment from buyers deliver within days
Beijing
Long-term effective
2020-11-19 14:39
250
Company Profile
Nanjing Shuangwei Biotechnology Co., LtdBy certification [File Integrity]
Contact:shuangwei(Mr.)
Email:
Telephone:
Phone:
Area:Beijing
Address:Beijing
Website:http://www.shuangweibiotech.com/ http://shuangwei.cndpmotors.com/
Product Description
This device is indicated for the removal of leukocytes from one single unit of packed red cells or whole blood at blood bank before transfusion.
It can effectively prevent leukocyte carrying virus infection and other blood transfusion reactions.
Product Function
» Residual leukocytes consistently average: < 1 x 10E6.
» High red cell recovery rate: >90%.
» 100% removal of micro-aggregates.
» No prime needed before filtration.
» Transfer bag: 500ml.
http://www.shuangweibiotech.com/